Endophthalmitis Reducing Risk Across the Practice Spectrum

Endophthalmitis: Reducing Risk Across the Practice Spectrum
1 AMA PRA Category 1 Credit(s)
Launch Date:
June 04, 2015
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

Ophthalmologists, Retinal Specialists

Relevant Terms:


Charles Wykoff, MD, PhD​

​Charles Wykoff, MD, PhD​
Co-director, Greater Houston Retina Research Foundation with Retina Consultants of Houston
Houston, Texas

Charles Wykoff, MD, PhD, is co-director of the Greater Houston Retina Research Foundation with Retina Consultants of Houston. He graduated Phi Beta Kappa from MIT, received his PhD from Oxford University in England while on a Marshall Scholarship, and his MD from Harvard Medical School. As a medical student, he co-authored the book Fighting Global Blindness. Dr. Wykoff completed his ophthalmology residency and vitreoretinal fellowship at Bascom Palmer Eye Institute, the top rated eye hospital in the country; while there he was awarded a Heed Fellowship, the Ronald G. Michels Fellowship Award, the nation’s highest honor for a retina surgery fellow, and served as chief resident/co-director of Ocular Trauma.
Dr. Wykoff’s research interests pertain to angiogenesis and retinal vascular diseases, including age-related macular degeneration, diabetic retinopathy, and venous occlusive diseases as well as vitreoretinal surgery topics such as retinal detachment and macular surgery. Dr. Wykoff has written and published more than 120 peer-reviewed scientific manuscripts, book chapters, national meeting presentations and abstracts. Dr. Wykoff is an elected member of the Retina Society and the Macula Society, serves as the academic program director for the Vit-Buckle Society Meeting, and is a member of the American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology, American Society of Retina Specialists, and Fellow of the American College of Surgeons.

D. Wilkin Parke III, MD

D. Wilkin Parke III, MD
Vitreoretinal specialist, VitreoRetinal Surgery, PA
Minneapolis, Minnesota

D. Wilkin Parke III, MD, is a vitreoretinal specialist with VitreoRetinal Surgery, PA, in Minneapolis, Minnesota. He received a degree in history with a pre-medical focus from Princeton University. He attended medical school at Baylor College of Medicine in Houston, Texas, where he graduated with honors. Dr. Parke completed an internship in Internal Medicine through the University of Oklahoma. He completed his residency and surgical retina fellowship at Bascom Palmer Eye Institute in Miami, Florida. During his last year of fellowship, he was chief resident at Bascom Palmer as well as director of the Ocular Trauma Service. Dr. Parke joined VitreoRetinal Surgery, PA in 2013.

Sonia H. Yoo, MD

Sonia H. Yoo, MD
Professor of Ophthalmology
Associate Medical Director, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine
Miami, Florida

Sonia H. Yoo, MD, is currently professor of ophthalmology with a joint appointment in biomedical engineering and associate medical director at Bascom Palmer Eye Institute, University of Miami Miller School of Medicine. Dr. Yoo received her BA at Stanford University in California and her MD at Case Western Reserve University in Ohio. She completed residency and fellowship at Massachusetts Eye and Ear Infirmary of Harvard Medical School in 1998.
Dr. Yoo's areas of clinical practice are cornea, cataract, and refractive surgery. Her areas of research interest are in laser applications in cornea, cataract and refractive surgery, and restoring accommodation. She holds several patents and has authored more than 150 book chapters and peer-reviewed journal articles as well as serving as the principal investigator in numerous drug and device trials.
Dr. Yoo has a history of service to her field. This year, Dr. Yoo served as the program chair of the Refractive Surgery subspecialty day program of the American Academy of Ophthalmology (AAO) and received the International Society of Refractive Surgery's prestigious Founder's Award for her accomplishments in cataract and refractive surgery. She serves on the AAO's Practicing Ophthalmologists Curriculum Refractive Management/Intervention Panel for refractive surgery, is a board member of the American Society of Cataract and Refractive Surgery, and is on the board of directors for the Cornea Society. She is a reviewer for numerous ophthalmology journals and serves on the editorial board of the Cornea Society, the Journal of Refractive Surgery, and the Journal of Cataract and Refractive Surgery. Dr. Yoo served as the cornea fellowship director at Bascom Palmer Eye Institute from 2000–2013 and has trained numerous residents, clinical fellows, and international research fellows during her career.
Performing eye surgery for the past 20 years, Dr. Yoo continually strives to improve patient outcomes. She is currently working on the use of optical coherence tomography imaging to aid visualization during surgery. She is also using this technology to develop a novel imaging device for the early detection of keratoconus.
1. Identify patients at increased risk for developing endophthalmitis based on its various causes and risk factors
2. Institute the most effective preventive methods to reduce the risk of endophthalmitis
3. Implement evidence-based diagnostic and management approaches for endophthalmitis

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and RMEI, LLC. Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflicts of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
  • Charles C. Wykoff, MD, PhD, has affiliations with Genentech, Regeneron, Alcon, and Allergan (Consulting, Speakers' Bureau, Research)
  • D. Wilkin Parke III, MD, has affiliations with Bayer (Speakers' Bureau).
  • Sonia H. Yoo, MD, has affiliations with Alcon, AMO, Allergan, Bioptigen, Carl Zeiss Meditec, Transcend Medical (Consulting); AMO, Avedro (Research).
  • Jacqui Brooks, MBBCh, MRCPsych, has no affiliations with commercial interests relative to the content to disclose.
  • Amy Reeve, has no affiliations with commercial interests relative to the content to disclose.
Postgraduate Institute for Medicine
The following PIM planners and managers, Judi Smelker-Mitchek, RN, BSN, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CCMEP, and Jan Schultz, MSN, RN, CCMEP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Estimated time to complete: 1.0 hour
Medium: Internet

There is no fee for this educational activity.

This activity is supported by an independent educational grant from Genentech.

By reviewing the course content and successfully completing the post-test and evaluation, physicians, nurse practitioners, and physician assistants are entitled to receive up to 1.0 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page. Users must:
  • Read the learning objectives and faculty disclosures.
  • Participate in the activity.
  • Complete the post-test and activity evaluation.
Physicians, nurse practitioners, and physician assistants who successfully complete the post-test and evaluation will receive CME/CE credit. You must score 75% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
Supported Browsers:
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6+ for Mac OSX 10.7 and above

For video playback, install the latest version of Flash or Quicktime.